000 01864nam a2200457 i 4500
001 ocn962261452
003 OCoLC
005 20170826160833.0
006 m o d f
007 cr mn|||||||||
008 161108s2006 dcu o f000 0 eng c
040 _aGPO
_beng
_erda
_epn
_cGPO
042 _apcc
043 _an-us---
074 _a0445-B-07 (online)
086 0 _aHE 1.75:OEI-05-06-00090
088 _aOEI-05-06-00090
099 _aHE 1.75:OEI-05-06-00090
110 1 _aUnited States.
_bDepartment of Health and Human Services.
_bOffice of Inspector General,
_eauthor.
245 1 0 _aDual eligibles' transition :
_bPart D formularies' inclusion of commonly used drugs.
246 3 0 _aPart D formularies' inclusion of commonly used drugs
246 1 _iRunning title:
_aDual Eligibles' transition : Part D formularies' inclusion of commonly used drugs
264 1 _a[Washington, D.C.] :
_bDepartment of Health and Human Services, Office of Inspector General,
_c2006.
300 _a1 online resource (iv, 55 pages)
337 _2rdamedia
338 _2rdacarrier
588 _aDescription based on online resource; title from PDF title page (HHS, viewed Nov. 4, 2016).
500 _a"January 2006."
500 _a"OEI-05-06-00090."
500 _aCRDP Project record.
504 _aIncludes bibliographical references (pages 19-24).
650 0 _aMedicare beneficiaries.
650 0 _aMedicaid beneficiaries.
650 0 _aPoor
_xServices for
_zUnited States.
650 0 _aPharmaceutical services insurance
_zUnited States.
610 1 0 _aUnited States.
_tMedicare Prescription Drug, Improvement, and Modernization Act of 2003.
776 0 8 _iPrint version:
_tDual eligibles' transition
_w(OCoLC)63790373
856 4 0 _uhttp://purl.fdlp.gov/GPO/gpo74210
949 _aBEV
_bFed Docs
942 _c3
999 _c265537
_d265537